WuXi AppTec (OTCMKTS:WUXAY) Shares Gap Up – Should You Buy?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) gapped up prior to trading on Monday . The stock had previously closed at $23.51, but opened at $25.2644. WuXi AppTec shares last traded at $25.2644, with a volume of 218 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research upgraded WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Strong Buy”.

WuXi AppTec Trading Up 7.5%

The stock’s fifty day simple moving average is $22.94 and its 200-day simple moving average is $18.43.

WuXi AppTec Company Profile

WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.

The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.

Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.